{
    "clinical_study": {
        "@rank": "87360", 
        "arm_group": {
            "arm_group_label": "Renal Denervation", 
            "arm_group_type": "Experimental", 
            "description": "Renal Denervation using the Kona Surround Sound Externally Focused Therapeutic Ultrasound therapy."
        }, 
        "brief_summary": {
            "textblock": "This study will evaluate the effects of renal denervation using externally focused\n      therapeutic ultrasound with external targeting and tracking on patients with refractory\n      hypertension."
        }, 
        "brief_title": "Renal Denervation Using Externally Focused Therapeutic Ultrasound", 
        "completion_date": {
            "#text": "April 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Hypertension", 
        "condition_browse": {
            "mesh_term": "Hypertension"
        }, 
        "detailed_description": {
            "textblock": "This study is a prospective, multi-center trial wherein each included subject will receive\n      the experimental externally focused ultrasound renal denervation therapy. It will be\n      conducted on a maximum of twenty patients who meet the eligibility criteria and have signed\n      the informed consent form.\n\n      Safety is the primary endpoint of this study. Safety will be assessed by incidence and\n      evaluation of any serious adverse effects associated with the investigational procedure\n      through the 52-week evaluation.  Clinical utility is a secondary endpoint of this study.\n      Clinical utility will be evaluated by comparing pre and post therapy systolic and diastolic\n      blood pressure."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  At least 18 years of age\n\n          -  Average systolic blood pressure at least 160 mmHg\n\n          -  Refractory, stable hypertension despite being treated with at least three\n             hypertensive drugs\n\n          -  Two functioning kidneys, defined as eGFR >= 45 ml/min\n\n          -  At least one renal artery on each side which is greater than 4 mm.\n\n        Exclusion Criteria:\n\n          -  History of nephrectomy or hydronephrosis\n\n          -  Renal stenosis > 50%\n\n          -  Renal stent\n\n          -  Ambulatory blood pressure monitoring 24 hour average systolic blood pressure <= 135\n             mmHg\n\n          -  Kidney stones which are symptomatic and/or > 1 cm\n\n          -  History of abdominal surgery within the past 6 months\n\n          -  Heterogeneities in the kidneys (cysts or tumors)\n\n          -  Residual pyelonephritis\n\n          -  History of myocardial infarction, unstable angina pectoris, or cerebrovascular\n             accident within the last 6 months\n\n          -  Hemodynamically significant valvular heart disease\n\n          -  Implantable cardioverter defibrillator, pacemaker, neurostimulator or other device\n             incompatible with MRI\n\n          -  Body weight > 150 kilograms\n\n          -  Target treatment depth > 14 cm from the skin line\n\n          -  Pregnant, nursing or intends to become pregnant during the trial period"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "20", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "August 19, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01926951", 
            "org_study_id": "KM13-001"
        }, 
        "intervention": {
            "arm_group_label": "Renal Denervation", 
            "description": "Externally Focused Therapeutic Ultrasound using the Kona Surround Sound System", 
            "intervention_name": "Surround Sound Externally Focused Therapeutic Ultrasound", 
            "intervention_type": "Device"
        }, 
        "is_fda_regulated": "No", 
        "keyword": "hypertension", 
        "lastchanged_date": "January 6, 2014", 
        "location": [
            {
                "contact": {
                    "email": "tereza.mikusova@fnusa.cz", 
                    "last_name": "Tereza Mikusova, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Brno", 
                        "country": "Czech Republic"
                    }, 
                    "name": "St. Anne's University Hospital"
                }, 
                "investigator": {
                    "last_name": "Zdnek Starek, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "Martina.Goldbergova@homolka.cz", 
                    "last_name": "Martina Goldbergov\u00e1"
                }, 
                "facility": {
                    "address": {
                        "city": "Prague", 
                        "country": "Czech Republic"
                    }, 
                    "name": "Nemocnice Na Homolee Hospital"
                }, 
                "investigator": {
                    "last_name": "Petr Neuzil, M.D.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "Barbara@mercyangiography.co.nz", 
                    "last_name": "Barbara Joppa"
                }, 
                "facility": {
                    "address": {
                        "city": "Aukland", 
                        "country": "New Zealand"
                    }, 
                    "name": "Mercy Angiography"
                }, 
                "investigator": {
                    "last_name": "John Ormiston, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": [
                "Czech Republic", 
                "New Zealand"
            ]
        }, 
        "number_of_arms": "1", 
        "official_title": "A Feasibility Study: An Evaluation of Renal Denervation Using Externally Focused Therapeutic Ultrasound With External Targeting and Tracking on Patients With Refractory Hypertension", 
        "overall_contact": {
            "email": "kpeters@konamedical.com", 
            "last_name": "Kevin Peters"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "New Zealand: Medsafe", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "April 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Safety will be assessed by incidence and evaluation of any serious adverse effects associated with the investigational procedure through 52-week evaluation.  Included in this assessment will be the proportion of subjects with any of the following outcomes: 1) death, or 2) medical morbidity.", 
            "measure": "Safety", 
            "safety_issue": "Yes", 
            "time_frame": "52-week post-treatment"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01926951"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "Clinical utility will be evaluated by comparing pre and post therapy systolic and diastolic blood pressure.", 
            "measure": "Clinical Utility", 
            "safety_issue": "No", 
            "time_frame": "52-week post-treatment"
        }, 
        "source": "Kona Medical Inc.", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Kona Medical Inc.", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "September 2013", 
        "study_design": "Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "January 2014"
    }
}